<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00456677</url>
  </required_header>
  <id_info>
    <org_study_id>Heikki31</org_study_id>
    <nct_id>NCT00456677</nct_id>
  </id_info>
  <brief_title>Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma</brief_title>
  <acronym>Mino</acronym>
  <official_title>Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Downstate Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Downstate Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial of effects of minocycline as &quot;add-on&quot; therapy to adults with asthma with a history of
      requiring at least one episode of oral steroid therapy to control the disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a double-blind, placebo-controlled crossover study of adult asthmatics given
      minocycline 150 mg po BID or placebo as add-on therapy for eight weeks each. Each eight week
      arm is separated by a four week wash-out. Spirometry is performed at the baseline and end of
      each arm. Daily symptoms scores, peak flow rates, and oral steroid requirements are recorded.
      A standardized asthma quality of life symptoms assessment is made every four weeks (AQLQ,
      Juniper).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1996</start_date>
  <completion_date type="Actual">October 1, 2007</completion_date>
  <primary_completion_date type="Actual">October 1, 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Double blind, placebo-controlled. crossover study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in oral steroid therapy requirements.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement in symptoms scores</measure>
    <time_frame>8 weeks</time_frame>
    <description>Asthma Quality of Lifes Scores (AQLQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in spriometric parameters</measure>
    <time_frame>8 weeks</time_frame>
    <description>improvement in spirometric parameters including FEV1, FVC, FEV1/FVC, FEF25-75</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in morning and evening peak flow</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>decrease in rescue inhaler usage</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Minocycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Addition of minocycline 150 mg po twice daily to current asthma treatment regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebos</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Addition of placebo capsules po twice daily to current asthma treatment regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>minocycline</intervention_name>
    <description>addition of antibiotic minocycline as antiinflammatory agent in addition to standard of care regimen.</description>
    <arm_group_label>Minocycline</arm_group_label>
    <other_name>Minocin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Addition of oral placebo capsule in addition to standard of care regimen</description>
    <arm_group_label>Placebos</arm_group_label>
    <other_name>oral placebo capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult asthmatics

          -  History of or current use of oral steroids to control symptoms

        Exclusion Criteria:

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rauno Joks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of New York - Downstate Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2007</study_first_submitted>
  <study_first_submitted_qc>April 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2007</study_first_posted>
  <last_update_submitted>April 14, 2017</last_update_submitted>
  <last_update_submitted_qc>April 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York - Downstate Medical Center</investigator_affiliation>
    <investigator_full_name>Rauno Joks</investigator_full_name>
    <investigator_title>Associate Professor of Clinical Medicine</investigator_title>
  </responsible_party>
  <keyword>minocycline</keyword>
  <keyword>asthma</keyword>
  <keyword>oral corticosteroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>Minocycline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

